Cambridge, Mass – Cambridge-based Tsoi/Kobus & Associates recently announced that it has been selected to design the new National Cancer Center Singapore.
The National Cancer Center Singapore (NCCS) is a world leader for compassionate and innovative cancer treatment. Since opening in 1999, the facility, which treats nearly 75% of all cancer patients in Singapore and another 10% regionally, has experienced rapidly growing demand. Tsoi/Kobus & Associates will work with project partners CIAP and Kahler Slater to design a new NCCS that will feature medical, surgical, and radiation oncology services, including a proton beam therapy center.
“The National Cancer Center Singapore is a particularly fitting project for our team, drawing on our deep strengths in thoughtful and inventive healthcare design that integrates cutting edge technology within a soothing and comfortable healing environment,” says Erik Mollo-Christensen, principal at Tsoi/Kobus & Associates. “We are thankful for the opportunity.”